Decreased Alu methylation in type 2 diabetes mellitus patients increases HbA1c levels.


Journal

Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384

Informations de publication

Date de publication:
Sep 2023
Historique:
revised: 20 08 2023
received: 15 07 2023
accepted: 13 09 2023
medline: 6 11 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Alu hypomethylation is a common epigenetic process that promotes genomic instability with aging phenotypes, which leads to type 2 diabetes mellitus (type 2 DM). Previously, our results showed significantly decreased Alu methylation levels in type 2 DM patients. In this study, we aimed to investigate the longitudinal changes in Alu methylation levels in these patients. We observed significantly decreased Alu methylation levels in type 2 DM patients compared with normal (p = 0.0462). Moreover, our findings demonstrated changes in Alu hypomethylation over a follow-up period within the same individuals (p < 0.0001). A reduction in Alu methylation was found in patients with increasing HbA1c levels (p = 0.0013) and directly correlated with increased HbA1c levels in type 2 DM patients (r = -0.2273, p = 0.0387). Alu methylation in type 2 DM patients progressively decreases with increasing HbA1c levels. This observation suggests a potential association between Alu hypomethylation and the underlying molecular mechanisms of elevated blood glucose. Furthermore, monitoring Alu methylation levels may serve as a valuable biomarker for assessing the clinical outcomes of type 2 DM.

Identifiants

pubmed: 37743692
doi: 10.1002/jcla.24966
pmc: PMC10623537
doi:

Substances chimiques

Glycated Hemoglobin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e24966

Subventions

Organisme : Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation Grant No. RGNS 63#x2010;213
ID : RGNS 63#x2010;213
Organisme : The National Science and Technology Development Agency, Thailand
ID : P#x2010;19#x2010;50189

Informations de copyright

© 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Références

PLoS One. 2020 Jun 11;15(6):e0234578
pubmed: 32525932
Diabetes Care. 2022 Nov 1;45(11):2753-2786
pubmed: 36148880
Ann Hum Genet. 2020 Mar;84(2):114-124
pubmed: 31571208
PLoS One. 2013 Aug 21;8(8):e70386
pubmed: 23990903
Diabetes Metab Res Rev. 2022 Jan;38(1):e3482
pubmed: 34216101
J Nutr Health Aging. 2022;26(10):936-944
pubmed: 36259582
J Clin Lab Anal. 2023 Sep;37(17-18):e24966
pubmed: 37743692
Front Endocrinol (Lausanne). 2022 Jan 06;12:751885
pubmed: 35069435
Dig Dis Sci. 2022 May;67(5):1879-1889
pubmed: 33939149
PLoS One. 2020 Oct 23;15(10):e0240839
pubmed: 33095794
Mutagenesis. 2004 May;19(3):169-85
pubmed: 15123782
Endocrinology. 2021 Oct 1;162(10):
pubmed: 34363464
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Rev Assoc Med Bras (1992). 2019 Jan;65(1):51-55
pubmed: 30758420
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
Aging Male. 2020 Dec;23(5):1098-1102
pubmed: 31615320
Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e566s
pubmed: 30328953
PLoS One. 2022 Jul 8;17(7):e0270004
pubmed: 35802708
J Nanosci Nanotechnol. 2018 Jun 1;18(6):3925-3935
pubmed: 29442728
J Diabetes Sci Technol. 2019 Jul;13(4):614-626
pubmed: 30636519
J Hum Genet. 2015 Jul;60(7):349-55
pubmed: 25833468
Expert Rev Endocrinol Metab. 2023 May;18(3):255-265
pubmed: 37078758
Int J Mol Sci. 2023 Jul 25;24(15):
pubmed: 37569258
Endocrinol Diabetes Metab. 2020 Nov 04;4(1):e00196
pubmed: 33532623
Nutrients. 2022 Jul 27;14(15):
pubmed: 35956261
Clin Interv Aging. 2022 Apr 29;17:653-664
pubmed: 35520948
Nutrients. 2022 Aug 04;14(15):
pubmed: 35956377
Medicine (Baltimore). 2020 Jun 5;99(23):e20530
pubmed: 32502009
Bioessays. 2023 Jan;45(1):e2200122
pubmed: 36404121
Korean J Ophthalmol. 2022 Feb;36(1):26-35
pubmed: 34743489
Oxid Med Cell Longev. 2017;2017:9270549
pubmed: 28194257
Clin Epigenetics. 2017 Aug 31;9:93
pubmed: 28883893
BMC Clin Pathol. 2013 Mar 19;13:10
pubmed: 23510117
Swiss Med Wkly. 2019 Oct 27;149:w20139
pubmed: 31656034
Biomed Pharmacother. 2018 Nov;107:306-328
pubmed: 30098549
J Transl Med. 2022 Feb 14;20(1):87
pubmed: 35164795
Biochem J. 2016 Dec 15;473(24):4527-4550
pubmed: 27941030
Rev Assoc Med Bras (1992). 2019 Jan;65(1):38-42
pubmed: 30758418
Diabetes Obes Metab. 2010 Apr;12(4):288-98
pubmed: 20380649
Front Cell Dev Biol. 2021 Nov 18;9:775507
pubmed: 34869377
Sci Rep. 2022 Jun 7;12(1):9363
pubmed: 35672376
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Diabetes Care. 2012 Jun;35(6):1364-79
pubmed: 22517736
Clin Diabetes. 2019 Jan;37(1):11-34
pubmed: 30705493
Int J Endocrinol. 2022 Jun 7;2022:2002768
pubmed: 35711333
FASEB Bioadv. 2022 Mar 28;4(6):408-434
pubmed: 35664831
BMC Med. 2022 Jan 10;20(1):2
pubmed: 35000594
Diabetes Ther. 2022 Feb;13(2):251-264
pubmed: 34962628
Epigenomics. 2018 Feb;10(2):175-185
pubmed: 29336607
BMC Pregnancy Childbirth. 2022 Jan 27;22(1):71
pubmed: 35086491
Biomark Insights. 2016 Jul 03;11:95-104
pubmed: 27398023
FASEB J. 2018 May 29;:fj201800218RR
pubmed: 29812972
Nucleic Acids Res. 2008 Jun;36(11):3667-75
pubmed: 18474527
Gene. 2018 Feb 5;642:542-548
pubmed: 29197589
Diabetes Metab Syndr Obes. 2022 May 11;15:1485-1494
pubmed: 35591908
Clin Epigenetics. 2020 Jul 11;12(1):104
pubmed: 32653024
Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):163-6
pubmed: 24643693
Arch Biochem Biophys. 2014 Sep 1;557:47-54
pubmed: 24820329
PLoS One. 2013 Aug 19;8(8):e72706
pubmed: 23977341
Int J Mol Sci. 2021 Oct 28;22(21):
pubmed: 34769081
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27048304
Am Fam Physician. 2016 Jan 15;93(2):103-9
pubmed: 26926406
Diabetologia. 2022 May;65(5):763-776
pubmed: 35169870
J Integr Med. 2023 May;21(3):226-235
pubmed: 36932029
Asian Pac J Cancer Prev. 2012;13(9):4469-75
pubmed: 23167363
J Biol Chem. 2019 Feb 15;294(7):2407-2421
pubmed: 30578299
Genet Couns. 2013;24(2):149-56
pubmed: 24032284
Curr Diab Rep. 2022 May;22(5):227-235
pubmed: 35305202
BMJ Open Diabetes Res Care. 2023 Feb;11(1):
pubmed: 36746527
Acta Diabetol. 2022 May;59(5):697-709
pubmed: 35112189
Nucleic Acids Res. 2021 Apr 6;49(6):3020-3032
pubmed: 33300031
Int J Physiol Pathophysiol Pharmacol. 2019 Jun 15;11(3):45-63
pubmed: 31333808

Auteurs

Jirapan Thongsroy (J)

School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Research Center in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat, Thailand.

Apiwat Mutirangura (A)

Center for Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University, Bangkok, Thailand.
Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH